{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:54:47Z","timestamp":1780617287433,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","award":["Unrestricted Educational Grant \/ No number"],"award-info":[{"award-number":["Unrestricted Educational Grant \/ No number"]}],"id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00408-018-0140-8","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T04:51:01Z","timestamp":1533012661000},"page":"543-552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tissue and Bronchoalveolar Lavage Biomarkers in Idiopathic Pulmonary Fibrosis Patients on Pirfenidone"],"prefix":"10.1007","volume":"196","author":[{"given":"Nicola","family":"Ronan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre M.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Dahly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Bourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Chelliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cavazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"O\u2019Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiachra","family":"Moloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Plant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8858-2938","authenticated-orcid":false,"given":"Michael T.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"140_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1164\/ajrccm.157.4.9707039","volume":"157","author":"AL Katzenstein","year":"1998","unstructured":"Katzenstein AL, Myers JL (1998) Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157:1301\u20131315","journal-title":"Am J Respir Crit Care Med"},{"key":"140_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJMra003200","volume":"345","author":"TJ Gross","year":"2001","unstructured":"Gross TJ, Hunninghake GW (2001) Idiopathic pulmonary fibrosis. N Engl J Med 345:517\u2013525","journal-title":"N Engl J Med"},{"key":"140_CR3","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S2213-2600[15]00048-X","volume":"3","author":"RG Jenkins","year":"2015","unstructured":"Jenkins RG, Simpson JK, Saini G, Bentley JH, Russell AM, Braybrooke R, Molyneaux PL, McKeever TM, Wells AU, Flynn A, Hubbard RB, Leeming DJ, Marshall RP, Karsdal MA, Lukey PT, Maher TM (2015) Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study. Lancet Respir Med 3:462\u2013472. https:\/\/doi.org\/10.1016\/S2213-2600%5B15%5D00048-X","journal-title":"Lancet Respir Med"},{"key":"140_CR4","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1183\/09031936.02.00022302","volume":"20","author":"MT Henry","year":"2002","unstructured":"Henry MT, McMahon K, Mackeral AJ, Prikk K, Sorsa T, Maisi P, Sepper R, FitzGerald MX, O\u2019Connor CM (2002) Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur Respir J 20:1220\u20131227","journal-title":"Eur Respir J"},{"key":"140_CR5","first-page":"228","volume":"32","author":"B Kennedy","year":"2015","unstructured":"Kennedy B, Branagan P, Moloney F, Haroon M, O\u2019Connor TM, O\u2019Regan K, Harney S, Henry MT (2015) Biomarkers to predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffus Lung Dis 32:228\u2013236","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"key":"140_CR6","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DH, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR for the IMPULSIS Trial Investigators (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370:2071\u20132082","journal-title":"N Engl J Med"},{"key":"140_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1183\/09031936.00005209","volume":"35","author":"H Taniguchi","year":"2010","unstructured":"Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Tagahashi Y, Nakata K, Sato A, Takeuchi M, Raghu G, Kudoh S, the Pirfenidone Clinical Study Group in Japan (2010) Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 35:821\u2013829","journal-title":"Eur Respir J"},{"key":"140_CR8","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","volume":"377","author":"PW Noble","year":"2011","unstructured":"Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE, Lancaster L, Sahn SA, Swarcberg J, Valeyre D, Du Bois RM for the CAPACITY study group (2011) Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 377:1760\u20131769","journal-title":"Lancet"},{"issue":"22","key":"140_CR9","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"E Gorina","year":"2014","unstructured":"Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW, for the ASCEND Study Group (2014) A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370(22):2083\u20132092","journal-title":"N Engl J Med"},{"issue":"120","key":"140_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1183\/09059180.00001111","volume":"20","author":"CJ Schaefer","year":"2011","unstructured":"Schaefer CJ, Ruhrmund DW, Pan L, Seiwert SD, Kossen K (2011) Antifibrotic activities of pirfenidone in animal models. Eur Respir Rev 20(120):85\u201397","journal-title":"Eur Respir Rev"},{"key":"140_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1183\/09059180.00003214","volume":"24","author":"G Bagnato","year":"2015","unstructured":"Bagnato G, Harari S (2015) Cellular interactions in the pathogenesis of interstitial lung diseases. Eur Respir Rev 24:102\u2013114","journal-title":"Eur Respir Rev"},{"issue":"7","key":"140_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1164\/rccm.201504-0711OC","volume":"193","author":"S Tomassetti","year":"2016","unstructured":"Tomassetti S, Wells AU, Costabel U, Cavazza A, Colby TV, Rossi G, Sverzellati N, Carloni A, Carretta E, Buccioli M, Tantalocca P, Ravaglia C, Gurioli C, Dubini C, Piciucchi S, Ryu JH, Poletti V (2016) Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 193(7):745\u2013752. https:\/\/doi.org\/10.1164\/rccm.201504-0711OC","journal-title":"Am J Respir Crit Care Med"},{"key":"140_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000203987","volume":"78","author":"A Babiak","year":"2009","unstructured":"Babiak A, Hetzel J, Krishna G, Fritz P, Moeller P, Balli T, Hetzel M (2009) Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration 78:203\u2013208","journal-title":"Respiration"},{"issue":"2","key":"140_CR14","doi-asserted-by":"publisher","first-page":"e86716","DOI":"10.1371\/journal.pone.0086716","volume":"9","author":"GL Casoni","year":"2014","unstructured":"Casoni GL, Tomassetti S, Cavazza A, Colby TV, Dubini A, Ryu JH, Caretta E, Tantalocco P, Piciucchi S, Ravaglia C, Gurioli C, Romagnoli M, Gurioli C, Chilosi M, Poletti V (2014) Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS ONE 9(2):e86716","journal-title":"PLoS ONE"},{"issue":"7","key":"140_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.5858\/arpa.2016-0233-RA","volume":"141","author":"TV Colby","year":"2017","unstructured":"Colby TV, Tomassetti S, Cavazza A, Dubini A, Poletti V (2017) Transbronchial cryobiopsy in diffuse lung disease: update for the pathologist. Arch Pathol Lab Med 141(7):891\u2013900","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"140_CR16","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1007\/s00330-011-2098-2","volume":"21","author":"AJ Edey","year":"2011","unstructured":"Edey AJ, Devaraj AA, Barker RP, Nicholson AG, Wells AU, Hansell DM (2011) Fibrotic idiopathic interstitial pneumonias HRCT findings that predict mortality. Eur Radiol 21(8):1586\u20131593","journal-title":"Eur Radiol"},{"issue":"8","key":"140_CR17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1128\/CVI.05032-11","volume":"18","author":"EC Breen","year":"2011","unstructured":"Breen EC, Reynolds SM, Cox C, Jacobson LP, Magpantay L, Mulder CB, Dibben O, Margolick JB, Bream JH, Sambrano E, Martinez-Mazo O, Sinclair E, Borrow P, Landay AL, Rinaldo CR, Norris PJ (2011) Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol 18(8):1229\u20131242","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"140_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jim.2008.10.002","volume":"340","author":"F Chowdhury","year":"2009","unstructured":"Chowdhury F, Williams A, Johnson P (2009) Validation and comparison of two multiplex technologies, Luminex\u00ae and Mesoscale Discovery, for human cytokine profiling. J Immunol Methods 340(1):55\u201364.","journal-title":"J Immunol Methods"},{"key":"140_CR19","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1186\/ar2766","volume":"11","author":"K Schmidt","year":"2009","unstructured":"Schmidt K, Martinez-Gamboa L, Meier S, Witt C, Meisel C, Hanitsch LG, Becker MO, Huscher D, Burmester GR, Riemekasten G (2009) Bronchoalveolar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients. Arthritis Res Ther 11:R111","journal-title":"Arthritis Res Ther"},{"key":"140_CR20","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/resp.12322","volume":"19","author":"V Pajares","year":"2014","unstructured":"Pajares V, Puzo C, Castillo D, Lerma E, Montero MA, Ramos-Barbo\u00b4 D, Amor-Carro O, Gil de Bernabe\u00b4 A, Franquet T, Plaza V, Hetzel J, Sanchis J, Torrego A (2014) Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial. Respirology 19:900\u2013906","journal-title":"Respirology"},{"issue":"6","key":"140_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D; ATS\/ERS Committee on Idiopathic Interstitial Pneumonias (2013) An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188(6):733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"140_CR22","first-page":"58","volume":"5","author":"NJ Lomas","year":"2012","unstructured":"Lomas NJ, Watts KL, Akram KM, Forsyth NR, Spiteri MA (2012) Idiopathic pulmonary fibrosis: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers. Int J Clin Exp Pathol 5(1):58\u201371","journal-title":"Int J Clin Exp Pathol"},{"key":"140_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-3-319-19992-4_10","volume-title":"Lecture Notes in Computer Science","author":"Junning Li","year":"2015","unstructured":"Li J, Shi Y, Toga AW (2015) Controlling false discovery rate in signal space for transformation-invariant thresholding of statistical maps. In: Information processing in medical imaging: proceedings of the conference. Lecture notes in computer science, vol 9123, pp 125\u2013136. https:\/\/doi.org\/10.1007\/978-3-319-19992-4_10"},{"key":"140_CR24","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.humpath.2009.01.006","volume":"40","author":"O El-Zammer","year":"2009","unstructured":"El-Zammer O, Rosenbaum P, Katzenstein AL (2009) Proliferative activity in fibrosing lung diseases: a comparative study of Ki-67 immunoreactivity in diffuse alveolar damage, bronchiolitis-organizing pneumonia, and usual interstitial pneumonia. Hum Pathol 40:1182\u20131188","journal-title":"Hum Pathol"},{"key":"140_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1378\/chest.130.1.22","volume":"130","author":"N Enomoto","year":"2006","unstructured":"Enomoto N, Suda T, Kato M, Kaida Y, Nakamura Y, Imokawa S, Ida M, Chida K (2006) Quantitative analysis of fibroblastic foci in usual interstitial pneumonia. Chest 130:22\u201329","journal-title":"Chest"},{"key":"140_CR26","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1164\/rccm.200204-373OC","volume":"167","author":"KR Flaherty","year":"2003","unstructured":"Flaherty KR, Colby TV, Travis WD, Toews GB, Mumford J, Murray S, Thannickal VJ, Kazarooni EA, Gross BH, Lynch JP, Martinez FJ (2003) Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 167:1410\u20131415","journal-title":"Am J Respir Crit Care Med"},{"key":"140_CR27","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1164\/rccm.201508-1632OC","volume":"93","author":"JP Hutchinson","year":"2016","unstructured":"Hutchinson JP, Fogarty AW, McKeever TM, Hubbard RB (2016) In-hospital mortality after surgical lung biopsy for interstitial lung biopsy in the United States, 2000\u20132011. Am J Respir Crit Care Med 93:1161\u20131167","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"140_CR28","doi-asserted-by":"publisher","first-page":"e86375","DOI":"10.1172\/jci.insight.86375","volume":"1","author":"MG Jones","year":"2016","unstructured":"Jones MG, Fabre A, Schneider P, Cinetto F, Sgalla G, Mavrogordato M, Jogai S, Alzetani A, Marshall BG, O\u2019Reilly KMA, Warner JA, Lackie PM, Davies DE, Hansell DM, Nicholson AG, Sinclair I, Brown KK, Richeldi L (2016) Three-dimensional characterisation of fibroblast foci in idiopathic pulmonary fibrosis. JCI Insight 1(5):e86375. https:\/\/doi.org\/10.1172\/jci.insight.86375","journal-title":"JCI Insight"},{"issue":"9","key":"140_CR29","doi-asserted-by":"publisher","first-page":"e45960","DOI":"10.1371\/journal.pone.0045960","volume":"7","author":"S Saito","year":"2012","unstructured":"Saito S, Murase K (2012) Detection and early phase assessment of radiation induced lung injury in mice using Micro-CT. PLoS ONE 7(9):e45960. https:\/\/doi.org\/10.1371\/journal.pone.0045960","journal-title":"PLoS ONE"},{"key":"140_CR30","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1164\/rccm.200802-313OC","volume":"178","author":"M Korfei","year":"2008","unstructured":"Korfei M, Ruppert C, Mahavadi P, Henneke I, Markart P, Koch M, Lang G, Fink L, Bohle RM, Seeger W, Weaver TE, Guenther A (2008) Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 178:838\u2013846","journal-title":"Am J Respir Crit Care Med"},{"key":"140_CR31","first-page":"867","volume":"19","author":"K Kuwano","year":"2004","unstructured":"Kuwano K, Hagimoto N, Nakanishi Y (2004) The role of apoptosis in pulmonary fibrosis. Histol Histopathol 19:867\u2013881","journal-title":"Histol Histopathol"},{"key":"140_CR32","doi-asserted-by":"publisher","first-page":"L316","DOI":"10.1152\/ajplung.2001.280.2.L316","volume":"280","author":"K Kuwano","year":"2001","unstructured":"Kuwano K, Kunitake R, Maeyama T, Hagimoto N, Kawasaki M, Matsuba T, Yoshimi M, Inoshima I, Yoshida K, Hara N (2001) Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 280:L316\u2013L325","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"140_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.TP.0000151721.99418.48","volume":"79","author":"F Shihab","year":"2005","unstructured":"Shihab F, Bennett WM, Hong Y, Andoh TF (2005) Effect of pirfenidone on apoptosis-regulatory genes in chronic cyclosporine nephrotoxicity. Transplantation 79:419\u2013426","journal-title":"Transplantation"},{"key":"140_CR34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1183\/09031936.93.06070951","volume":"6","author":"A Pforte","year":"1993","unstructured":"Pforte A, Gerth C, Voss A, Beer B, Haussinger K, Jutting U, Burger G, Zeigler-Heitbrock HW (1993) Proliferating alveolar macrophages in BAL and lung function changes in interstitial lung disease. Eur Respir J 6:951\u2013955","journal-title":"Eur Respir J"},{"key":"140_CR35","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1183\/09031936.00228513","volume":"43","author":"T Maher","year":"2014","unstructured":"Maher T (2014) Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era? Eur Respir J 43:1233\u20131236","journal-title":"Eur Respir J"},{"key":"140_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1183\/09059180.00003214","volume":"24","author":"G Bagnato","year":"2015","unstructured":"Bagnato G, Harari S (2015) Cellular mechanisms in the pathogenesis of interstitial lung diseases. Eur Respir Rev 24:102\u2013114","journal-title":"Eur Respir Rev"},{"key":"140_CR37","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1164\/rccm.2103112","volume":"166","author":"S Koyama","year":"2002","unstructured":"Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T (2002) Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 166:382\u2013385","journal-title":"Am J Respir Crit Care Med"},{"key":"140_CR38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1164\/rccm.200306-774OC","volume":"169","author":"P Tsao","year":"2004","unstructured":"Tsao P, Su Y, Hung L, Huang P, Chien C, Lai YL, Lee CN, Chen CA, Cheng WF, Wei SC, Yu CJ, Hsieh FJ, Hsu SM (2004) Overexpression of placental growth factor contributes to the pathogenesis of pulmonary emphysema. Am J Respir Crit Care Med 169:505\u2013511","journal-title":"Am J Respir Crit Care Med"},{"key":"140_CR39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1164\/rccm.2010014","volume":"166","author":"Y Inoue","year":"2002","unstructured":"Inoue Y, King TE, Barker E, Daniloff E, Newman LS (2002) Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med 166:765\u2013773","journal-title":"Am J Respir Crit Care Med"},{"key":"140_CR40","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1183\/09031936.02.00081102","volume":"19","author":"KE Greene","year":"2002","unstructured":"Greene KE, King TE Jr, Kuroki Y, Bucher-Bartelson B, Hunninghake GW, Newman LS, Nagae H, Mason RJ (2002) Serum surfactant proteins-A and \u2013D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J 19:439\u2013446","journal-title":"Eur Respir J"},{"key":"140_CR41","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/ajrccm.152.2.7633738","volume":"152","author":"FX McCormack","year":"1995","unstructured":"McCormack FX, King TE Jr, Bucher BL, Mielsen L, Mason RJ, McCormac FX (1995) Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 152:751\u2013759","journal-title":"Am J Respir Crit Care Med"},{"key":"140_CR42","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2478\/v10042-009-0028-9","volume":"47","author":"W Kucejko","year":"2009","unstructured":"Kucejko W, Chyczewska E, Naumnik W, Ossoli\u00f1ska M (2009) Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensitivity pneumonitis and idiopathic pulmonary fibrosis. Folia Histochem Cytobiol 47:225\u2013230","journal-title":"Folia Histochem Cytobiol"},{"key":"140_CR43","doi-asserted-by":"publisher","first-page":"L676","DOI":"10.1152\/ajpcell.1997.273.5.C1466","volume":"273","author":"JA Martinez","year":"1997","unstructured":"Martinez JA, King TE Jr, Browne K, Jennings CA, Borish L, Mortenson RL, Khan TZ, Bost TW, Riches DW (1997) Increased expression of interleukin-10 gene by alveolar macrophages in interstitial lung disease. Am J Physiol 273:L676\u2013L683","journal-title":"Am J Physiol"},{"key":"140_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1183\/09031936.03.00014703","volume":"22","author":"A Bergeron","year":"2003","unstructured":"Bergeron A, Soler P, Kambouchner M, Loiseau P, Milleron B, Valeyre D, Hance AJ, Tazi A (2003) Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-\u03b2 and IL-10. Eur Respir J 22:69\u201376","journal-title":"Eur Respir J"},{"key":"140_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0014-2999(02)01758-2","volume":"446","author":"H Nakazato","year":"2002","unstructured":"Nakazato H, Oku H, Yamane S, Tsuruta Y, Suzuki R (2002) A novel anti-fibrotic agent pirfenidone suppresses tumour necrosis factor-alpha at the translational level. Eur J Pharmacol 446:177\u2013185","journal-title":"Eur J Pharmacol"},{"key":"140_CR46","doi-asserted-by":"publisher","first-page":"L914","DOI":"10.1152\/ajplung.2000.278.5.L914","volume":"278","author":"T Arai","year":"2000","unstructured":"Arai T, Abe K, Matsuoka H, Yoshida M, Mori M, Goya S, Kida H, Nishino K, Osaki T, Tachibana L, Kaneda Y, Hayashi S (2000) Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 278:L914\u2013L922","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"140_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejphar.2011.12.025","volume":"678","author":"J Navarro-Partida","year":"2012","unstructured":"Navarro-Partida J, Martinez-Riso A, Gonzalez-Cuevas J, Arrevillaga-Bosoni G, Ortiz-Navarrete V, Armendariz-Borunda J (2012) Pirfenidone restricts Th2 differentiation in vitro and limits Th2 response in experimental liver fibrosis. Eur J Pharmacol 678:71\u201377","journal-title":"Eur J Pharmacol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-018-0140-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-018-0140-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-018-0140-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T01:58:16Z","timestamp":1693792696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-018-0140-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["140"],"URL":"https:\/\/doi.org\/10.1007\/s00408-018-0140-8","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"assertion":[{"value":"6 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}